Home / Conditions / Chromosomal Anomaly
Chromosomal Anomaly: when insurers say no, reviewers often say yes
In 37 published external-review decisions involving chromosomal anomaly, independent physician reviewers overturned the insurer’s denial 54.1% of the time.
Published decisions
37
2001–2026
Overturned
54.1%
20 denials reversed
Most-fought treatments for chromosomal anomaly
What insurers denied — and how those fights ended.
| Category | Decisions | Overturned |
|---|---|---|
| Speech Therapy | 6 | 33.3% |
| Genetic Genomic Test | 3 | 100% |
| Skill Nsg Vsts | 3 | 33.3% |
What the insurer actually argued
Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 29 | 55.2% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 8 | 50% |
Typical time to a decision
21 days
Most land between 10 and 21 days
Handled as urgent
24.3%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: The patient’s parent has requested authorization and coverage for Tobii Dynavox I-110 with Snap + Core First speech-generating device (SGD). The American Speech-Language-Hearing Association (ASHA) notes that communication services and supports should be based on individual communication needs, and should be evaluated, planned, and provided by an interdisciplinary team with expertise in communication and language form, content, and function, as well as in augmentative and alternative communication (AAC). Brady and colleagues report that individuals with disabilities should be able to access functioning AAC and other AT (assistive technology) services and devices at all times. Current medical literature supports the provision of an AAC device for individuals with disabilities who have been evaluated and found capable of using such a device.
Nature of Statutory Criteria/Case Summary: An enrollees parent has requested authorization and coverage for genomic exome sequencing analysis (CPT 81415 and 81416). This patients genetic condition, 4q deletion syndrome, is a phenotypically variable syndrome with a wide range of clinical presentations. Specific abnormalities are associated with terminal deletions, including cleft palate and congenital heart disease. Fogel and colleagues noted that clinical exome sequencing “is rapidly becoming the new standard for sequencing in genetic diagnostics, as all 21,000 genes in the human genome can be evaluated in an essentially unbiased manner.” The authors noted that in instances where phenotypic presentation does not yield a diagnosis, rather than embarking on a series of diagnostic tests, “exome sequencing could abbreviate or stop the diagnostic testing cascade by establishing the specific r…
Where the denial was upheld
Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient’s parent has requested authorization and coverage for 10 additional supervision hours over a six-month period (for a total of 100 supervision hours over a six-month period), one additional hour per week direct applied behavior analysis (ABA) services (for a total of 16 hours per week direct ABA services), and/or potty training to be included in the ABA therapy. The Council of Autism Service Providers (CASP) and ABA Coding Coalition guidelines provide insight into the level of support for treatment of this patient’s autism and associated delays. The CASP highlights that for ABA to be medically necessary, “A developmentally appropriate ABA assessment process must identify strengths and weaknesses across domains and potential barriers to progress.
Nature of Statutory Criteria/Case Summary: The patient’s parent has requested authorization and coverage for 10 additional supervision hours over a six-month period (for a total of 100 supervision hours over a six-month period), one additional hour per week direct applied behavior analysis (ABA) services (for a total of 16 hours per week direct ABA services), and/or potty training to be included in the ABA therapy. The Council of Autism Service Providers (CASP) and ABA Coding Coalition guidelines provide insight into the level of support for treatment of this patient’s autism and associated delays. The CASP highlights that for ABA to be medically necessary, “A developmentally appropriate ABA assessment process must identify strengths and weaknesses across domains and potential barriers to progress.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
How to use this in your appeal
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for chromosomal anomaly was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.